Precision Oncology News and My Gene Counsel have partnered to produce the “Genetic Testing Challenges in Oncology” series to highlight real-world issues that genetics experts and medical professionals are encountering as genetic tests are increasingly used in cancer care. Experts submit anonymized case reports to My Gene Counsel, and based on the details in these reports, Precision Oncology News writes a feature that describes the case history, the challenges encountered by professionals in dealing with the case, and strategies they used in response to challenges or errors. The features also include a discussion with My Gene Counsel genetic counseling experts on better approaches that could be considered if similar cases are encountered in the future. In publishing this series, our aim is to educate experts in the field and foster discussion. If you would like to submit a case report, please email firstname.lastname@example.org.Read More
Ellen T. Matloff, President and CEO of My Gene Counsel, breaks down the controversy surrounding the recent 60 Minutes episode on Preimplantation Genetic Diagnosis (PGD). Listen to find out what PGD means, how it’s used and why its purpose is often misinterpreted.
One genetic testing company recently grabbed headlines by announcing that for just $249 they will be offering a cancer gene panel that will test for 19 hereditary cancer genes. There is no doubt that low-cost options like these will break access to genetic testing wide open.
Cancer Bytes: By Ellen Matloff
Welcome to Cancer Bytes, featuring interviews with people touched by cancer. We hope that by listening to stories from cancer survivors we can help you through your process of healing and coping with the disease.